Malondialdehyde, glutathione, and nitric oxide levels in Toxoplasma gondii seropositive patients

Korean Journal of Parasitology

Volumn 46, Issue 4, 2008, Pages 293-295

  Karaman, Ulku ^a   Çelik, Tuncay ^a   Kiran, Tugba Raika ^a   Colak, Cemil ^b   Daldal, Nilgun Ulfet ^a  

^a INONU UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Glutathione; Malondialdehyde; Nitric oxide; Toxoplasma gondii

Indexed keywords

GLUTATHIONE; IMMUNOGLOBULIN G; MALONALDEHYDE; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; OPTICAL DENSITY; PARASITE EXAMINATION; PARASITE SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BLOOD; CELLULAR IMMUNITY; IMMUNOLOGY; OXIDATIVE STRESS; TOXOPLASMA;

TOXOPLASMA; TOXOPLASMA GONDII;

ANIMALS; GLUTATHIONE; HUMANS; IMMUNITY, CELLULAR; LIPID PEROXIDATION; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 63149088988     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2008.46.4.293     Document Type: Article

References (16)

1. Kang KM, Lee GS, Lee JH, Choi IW, Shin DW, Lee YH. Effects of INOS inhibitor on IFN-γ production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii. Korean J Parasitol 2004; 42: 175-183.
2. Deorari AK, Broor S, Maitreyi RS, Agarwal D, Kumar H, Paul VK, Singh M. Incidence, clinical spectrum and outcome of intrauterine infections in neonates. J Trop Pediatr 2000; 46: 155-159.
3. Yazar S, Kilic E, Saraymen R, Sahin I. Serum malondialdehyde leves in Toxoplasma seropositive patients. Ann Saudi Med 2003; 23: 413-415.
4. Nishikawa Y, Kawasa O, Vielemeyer O, Suzuki H, Joiner KA, Xuar X, Nagasawa H. Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors. Parasite Immunol 2007; 29: 375-385.
5. Koltas IS, Yucebilgic G, Bilgin R, Parsak CK, Sakman G. Serum malondialdehyde level in patients with cystic echinococcosis. Saudi Med J 2006; 27: 1703-1705.
6. Uchiyama M, Mihara M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 34: 271-8.
7. Gensert JM, Ratan RR. The metabolic coupling of arginine metabolism to nitric oxide generation by astrocytes. Antioxid Redox Signal 2006; 8: 5-6.
8. Aladag A, Turkoz Y, Ozerol IB. Nitric oxide and its neurophysiopathological effects. Turk J Med Sci 2000; 20: 107-111.
9. Ding M, Kwok LY, Schluter D, Clayton C, Soldati D. The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury. Mol Microbiol 2004; 51: 47-61
10. Fairbanks V, Klee GG. Biochemical aspects of hematology. In Tietz NW ed, Textbook of Clinical Chemistry. Philadelphia, USA. W.B. Saunders Co. 1986, p 1532-1534.
11. Rozenfeld C, Martinez R, Figueiredo RT, Bozza MT, Lima FR, Pires AL, Silva PM, Bonomo A, Lannes-Vieira J, De Souza W, Moura-Neto V. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun 2003; 71: 2047-2057.
12. Daubener W, Posdziech V, Hadding U, Mackenzie CR. Inducuble anti-parasitic effector mechanisms in human uropethelial cells: tryptophan degradation vs. NO production. Med Microbiol Immunol 1999; 187: 143-147.
13. Yazar S, Kilic E, Saraymen R, Ozbilge H. Serum malondialdehyde levels in patients infected with plasmodium. West Indian Med 2004; 53: 147-149.
14. Atambay M, Karabulut AB, Aycan OM, Kilic E, Yazar S, Saraymen R, Karaman U, Daldal N. Dust-mites: effect on lipid peroxidation. Natl Med J India 2006; 19: 75-77.
15. Akkus I. Effects of free radicals and pathophysiological. Konya, Turkey. Mimoza Publisher: 32 ISBN 975-543-038-5. 1995, p 1-76.
16. Mercan U. The importance of free radicals in toxicology. YYU J Vet Faculty 2004; 15: 91-96.